Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs.
Monti JM, Debellis J, Alterwain P, Pellejero T, Monti D · 1987 · International journal of clinical pharmacology research 7(2):105-110
What does this source report?
Reported improvements were of little clinical significance. Apparent stage-2/NREM differences were already present at baseline; slow-wave and REM sleep were unchanged.
- Population and setting
- Patients with chronic insomnia; double-blind crossover
- Evidence type
- Clinical trial / comparison
- Preparation
- Ordinary DSIP
- Source language
- eng
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Baseline differences complicate interpretation; sample size is not provided in the indexed abstract.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed metadata and abstract checked via PubMed / Europe PMC; full methods and risk-of-bias assessment pending.
Recorded source-check date: 2026-10-01. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Monti JM, Debellis J, Alterwain P, Pellejero T, Monti D. Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs. International journal of clinical pharmacology research 7(2):105-110 1987.
Molekul research summary: https://molekul.io/research/dsip-3583493. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry